Skip to main content
Log in

UMC investigates use of observational data to id ADRs

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Norén GN, et al. Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System. Drug Safety 36 (Suppl.): 107-121, No. 1, Oct 2013. Available from: URL: http://dx.doi.org/10.1007/s40264-013-0095-x

  2. Ryan PB, et al. A Comparison of the Empirical Performance of Methods for a Risk Identification System. Drug Safety 36 (Suppl.): 143-158, No. 1, Oct 2013. Available from: URL: http://dx.doi.org/10.1007/s40264-013-0108-9

  3. Schuemie MJ, et al. Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases. Drug Safety 36 (Suppl.): 159-169, No. 1, Oct 2013. Available from: URL: http://dx.doi.org/10.1007/s40264-013-0109-8

  4. The Uppsala Monitoring Centre. Analysis of patient records and insurance claims can help identify side-effects of drugs. Media Release : 5 Nov 2013. Available from: URL: http://www.who-umc.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

UMC investigates use of observational data to id ADRs. Reactions Weekly 1481, 2 (2013). https://doi.org/10.1007/s40278-013-7552-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-7552-2

Navigation